Menopause News

CHICAGO — Many midlife women experience hypoactive sexual desire disorder, impacting both partner relationships and mental health, but FDA-approved treatments are available, according to a speaker.

Hormone therapy use markedly declined among postmenopausal women of all ages, races and ethnicities in the U.S. during the past 2 decades, according to findings published in JAMA Health Forum.

Hormonal therapy may delay glaucoma onset in postmenopausal women, with longer duration of treatment linked to later diagnosis of glaucoma, according to a study in Investigative Ophthalmology & Vision Science.

CHICAGO — For menopausal women experiencing disruptive, bothersome hot flashes, some relief may come from visiting a snowy landscape by slipping on a virtual reality headset, according to a speaker.

CHICAGO — Menopausal women who participated in weekly cognitive behavioral therapy sessions reported improvements in sexual function and depression and anxiety symptoms, researchers reported at the Annual Meeting of The Menopause Society.

CHICAGO — A meta-analysis suggests clinical hypnosis is more effective than cognitive behavioral therapy for reducing hot flash frequency and severity for menopausal women, researchers said at the Annual Meeting of The Menopause Society.

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker at the Annual Meeting of The Menopause Society.

CHICAGO — In this Healio video exclusive, Susan D. Reed, MD, MPH, MS, past president of The Menopause Society, highlights a new pilot program created to improve funding for research in menopause health, with up to four awards of $25,000 each.

The FDA issued a warning that use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, can cause rare but serious liver injury, according to an agency press release.